Add like
Add dislike
Add to saved papers

Assorted applications of N-substituted-2,4-thiazolidinediones in various pathological conditions.

Thiazolidine-2,4-dione (TZD), one of the most frequently encountered heterocyclic ring which has been implicated in design and synthesis of entities for various pathogenic conditions including cancer. Since its discoveryvarious substitutions at 5th position has been carried out and reviewed. Various substitutions at 5th position has led to generation of glitazones, whose target peroxisome proliferating activated receptor γ (PPARγ) was found decade after their discovery.Acidichydrogen (-NH) of TZD is prime pharmacophoric requirement for activation of PPARγ. However, advanced in silico techniques have helped to design compounds bearing substitutions at both methylene and -NH group of TZD, targeting range of enzymes involved in various pathological conditions viz.,diabetes, hyperlipidemia, infectious disease, inflammation and cancer. The promising activities shown by methylene and N-substituted TZDsin above mentioned therapeutic areas, prompted us to collate the information which would help researchers to alter the structure of existing ligands and to design new TZD derivatives with better safety and efficacy profiles.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app